Psychiatry Research
Volume 129, Issue 1 , Pages 65-73 , 30 November 2004

Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects

  • José Manuel De la Fuente

      Affiliations

    • Department of Psychiatry, Erasme Hospital, Free University of Brussels, 808 route de Lennik, B-1070 Brussels, Belgium
    • Faculty of Medicine, Oviedo University, Julian Clavería 6, 33006 Oviedo, Spain
    • Hôpital Psychiatrique de Lannemezan, Route de Toulouse, F-65300 Lannemezan, France
    • Corresponding Author InformationCorresponding author. Hôpital Psychiatrique de Lannemezan, Route de Toulouse, F-65300 Lannemezan, France. Tel.: +33 5 62 99 55 25; fax: +33 5 62 99 53 05.
    • ,
  • Julio Bobes

      Affiliations

    • Faculty of Medicine, Oviedo University, Julian Clavería 6, 33006 Oviedo, Spain
    • ,
  • Ignacio Morlán

      Affiliations

    • Faculty of Computer Science, Basque Country University, Campus de Guipúzcoa, San Sebastián, Spain
    • ,
  • María Teresa Bascarán

      Affiliations

    • Faculty of Medicine, Oviedo University, Julian Clavería 6, 33006 Oviedo, Spain
    • ,
  • Coro Vizuete

      Affiliations

    • Hôpital Psychiatrique de Lannemezan, Route de Toulouse, F-65300 Lannemezan, France
    • ,
  • Paul Linkowski

      Affiliations

    • Department of Psychiatry, Erasme Hospital, Free University of Brussels, 808 route de Lennik, B-1070 Brussels, Belgium
    • ,
  • Julien Mendlewicz

      Affiliations

    • Department of Psychiatry, Erasme Hospital, Free University of Brussels, 808 route de Lennik, B-1070 Brussels, Belgium

Received 20 March 2003 ,Revised 19 January 2004 ,Accepted 17 May 2004.

References 

  1. Adamson J, Burdick JA. Sleep of dry alcoholics. Archives of General Psychiatry. 1973;28:146–149
  2. Akiskal HS, Boghos LY, Davis GC, King D, Lemmi H. The nosologic status of borderline personality. Clinical and polysomnographic study. American Journal of Psychiatry. 1985;142:192–198
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed.. Washington, DC: American Psychiatric Press; 1987;
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  5. A Research Agenda for DSM-V. In:  Kupfer DJ,  First MB,  Regier DA editor. Washington, DC: American Psychiatric Press; 2002;
  6. Angst J, Merikangas K, Scheidegger P, Wicki W. Recurrent brief depression: a new subtype of affective disorder. Journal of Affective Disorders. 1990;19:87–98
  7. Angst J, Sellaro R, Merikangas K. Depressive spectrum diagnoses. Comprehensive Psychiatry. 2000;41:39–47
  8. Asaad T, Okasha T, Okasha A. Sleep EEG findings in ICD-10 borderline personality disorder in Egypt. Journal of Affective Disorders. 2002;71:11–18
  9. Battaglia M, Ferini-Strambi L, Smirne S, Bernardeschi L, Bellodi L. Ambulatory polysomnography of never-depressed borderline subjects. A high-risk approach to rapid eye movement latency. Biological Psychiatry. 1993;33:326–334
  10. Battaglia M, Ferini-Strambi L, Bertella S, Bajo S, Bellodi L. First-cycle REM density in never-depressed subjects with borderline personality disorder. Biological Psychiatry. 1999;45:1056–1058
  11. Baxter L, Edell W, Gerner R, Fairbanks Z, Gwirtsman H. Dexamethasone suppression test and Axis-I diagnoses of inpatients with DSM-III borderline personality disorder. Journal of Clinical Psychiatry. 1984;45:150–301
  12. Beeber AR, Kline MDD, Pie RW, Manning JM. Dexamethasone suppression test in hospitalised depressed patients with borderline personality disorder. Journal of Nervous and Mental Diseases. 1984;172:301–303
  13. Bell J, Lycaki H, Jones D, Kelwala S, Sitaram N. Effect of preexisting borderline personality disorder on clinical and EEG sleep correlates of depression. Psychiatry Research. 1983;9:115–123
  14. Benca MH, Obermeyer WH, Ronald A, Thisted RA, Gillin JC. Sleep and psychiatric disorders: a meta-analysis. Archives of General Psychiatry. 1992;49:651–668
  15. Benson KL, King R, Gordon D, Silva JA, Zarcone VP. Sleep patterns in borderline personality disorder. Journal of Affective Disorders. 1990;18:267–273
  16. Caldwell D, Domino E. Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients. Electroencephalography and Clinical Neurophysiology. 1967;22:414–420
  17. Carroll BJ, Greden J, Feinberg M, Lohr N, James JM, Steiner M, et al. Neuroendocrine evaluation of depression in borderline patients. Psychiatric Clinics of North America. 1981;4:67–75
  18. Coid WJ. An affective syndrome in psychopaths with borderline personality disorder. British Journal of Psychiatry. 1993;162:641–650
  19. Cole JO, Salomon M, Gunderson J. Drug therapy in borderline patients. Comprehensive Psychiatry. 1984;25:249–254
  20. Corominas A, Bonet P, Nieto E. Recurrent brief depression successfully treated with lithium. Biological Psychiatry. 1998;44:927–929
  21. De la Fuente JM, Lotstra F. A trial of carbamazepine in borderline personality disorder. European Neuropsychopharmacology. 1994;4:479–486
  22. De La Fuente JM, Mendlewicz J. TRH-stimulation and dexamethasone suppression in borderline personality disorder. Biological Psychiatry. 1996;40:412–418
  23. De La Fuente JM, Bobes J, Vizuete C, Mendlewicz J. Sleep-EEG in borderline patients without concomitant major depression. A comparison with major depressives and controls. Psychiatry Research. 2001;105:87–95
  24. De La Fuente JM, Bobes J, Vizuete C, Mendlewicz J. Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression. Journal of Psychiatric Research. 2002;36:137–145
  25. De La Fuente JM, Bobes J, Vizuete C, Mendlewicz J. Effects of carbamazepine on dexamethasone suppression and S-EEG in borderline personality disorder. Neuropsychobiology. 2002;45:113–119
  26. De La Fuente JM, Bobes J, Vizuete C, Mendlewicz J. Erratum to biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression. Journal of Psychiatric Research. 2002;36:267–268
  27. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry. 1978;35:837–844
  28. Feinberg I, Braun M, Koresko RL, Gottlieb F. Stage 4 sleep in schizophrenia. Archives of General Psychiatry. 1969;45:262–266
  29. Giles DE, Roffwarg HP, Rush AJ. REM latency threshold values in depression and normal control, sensitivity and specificity data. Sleep Research. 1987;16:272
  30. Gunderson JG. The relatedness of borderline and schizophrenic disorders. Schizophrenia Bulletin. 1979;5:17–22
  31. Gunderson JG, Kolb JE, Austin V. The Diagnostic Interview for Borderline Patients (DIB). American Journal of Psychiatry. 1981;138:896–903
  32. Joffe RT. Tranylcypromine in recurrent brief depression: two case reports. International Clinical Psychopharmacology. 1996;11:287–288
  33. Kavoussi RJ, Coccaro EF, Klar H, Lesser J, Siever LJ. The TRH stimulation test in DSM-III personality disorder. Biological Psychiatry. 1993;34:234–239
  34. Kerkhofs M, Hoffmann G, De Martelaere V, Linkowski P, Mendlewicz J. S-EEG recordings in depressive disorders. Journal of Affective Disorders. 1985;9:47–53
  35. King R, Benson KL, Zarcone VP. REM latency in borderlines and controls. Sleep Research. 1987;16:280
  36. Kontaxakis V, Markianos M, Vaslamatzis G, Markidis M, Kanellos P, Stefanis C. Multiple neuroendocrinological responses in borderline personality disorder patients. Acta Psychiatrica Scandinavica. 1987;76:593–597
  37. Korzekwa M, Steiner M, Links P, Eppel A. The dexamethasone suppression test in borderlines: is it useful?. Canadian Journal of Psychiatry. 1991;36:26–28
  38. Korzekwa M, Links P, Steiner M. Biological markers in borderline personality disorder: new perspectives. Canadian Journal of Psychiatry. 1993;38:s11–s15
  39. Krishnan RR, Davidson JRT, Rayasam K, Shope F. The dexamethasone suppression test in borderline personality disorder. Biological Psychiatry. 1984;19:1149–1153
  40. In:  Kupfer DJ,  First MB,  Regier DA editor. A Research Agenda for DSM-V. Washington, DC: American Psychiatric Press; 2002;
  41. Lahmeyer HW, Val EF, Gaviria FM, Prasad RB, Pandey NG, Rodgers P, et al. EEG sleep, lithium transport, dexamethasone suppression and monoamine oxidase activity in borderline personality disorder. Psychiatry Research. 1988;25:19–30
  42. Lepine JP, Pelissolo A, Weiller E, Boyer P, Lecrubier Y. Recurrent brief depression: clinical and epidemiological issues. Psychopathology. 1995;28:86–94
  43. Lester B, Rundell O, Cowden L. Alcohol and sleep in the chronic alcoholic. In:  Burch N,  Altshuler H editor. Behavior and Brain Electrical Activity. New York: Plenum Press; 1973;p. 55–80
  44. McNamara EM, Reynolds CF, Soloff PH, Mathias R, Rossi A, Spiker D, et al. EEG sleep of depression in borderline patients. American Journal of Psychiatry. 1984;141:182–186
  45. Montgomery SA. Recurrent brief depression. In:  Feighner JP,  Boyer WF editor. The Diagnosis of Depression. Chichester, UK: Wiley and Sons; 1991;p. 119–134
  46. Nathan SR, Soloff PH, George A, Peters J, McCarthy T. DST and TRH tests in borderline personality disorders. In:  Shagass C,  Josiassen RC editor. Biological Psychiatry-1985. New York: Elsevier Science Publishing; 1986;p. 566–568
  47. Pezawas L, Stamenkovic M, Aschauer N, Moffat R, Kasper S. Successful treatment of recurrent brief depression with reboxetine—a single case analysis. Pharmacopsychiatry. 2002;35:75–76
  48. Rechtschaffen, A., Kales, A.A., (Eds.), 1968. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stage of Human Subjects. NIH Publication #204. Superintendent of Documents, U.S. Government Printing Office, Washington, DC.
  49. Reynolds CF, Soloff PH, Kupfer DJ, Taska LS, Restifo K, Coble PA, et al. Depression in borderline patients, a prospective EEG sleep study. Psychiatry Research. 1985;14:1–15
  50. Rogers JH, Widiger TA, Krupp A. Aspects of depression associated with borderline personality disorder. American Journal of Psychiatry. 1995;152:268–270
  51. Schulz PM, Soloff PH, Kelly T, Morgenstern M, Di Franco R, Schulz SC. A family study of borderline subtypes. Journal of Personality Disorders. 1989;3:217–229
  52. Siever LH, Coccaro EF, Klar H, Losonczy MF, Wagner BH, Weiss KJ, et al. Biological markers in borderline and related personality disorders. In:  Shagass C,  Josiassen RG,  Wagner BH editor. Biological Psychiatry: Proceedings of the IVth World Congress of Biological Psychiatry. New York: Elsevier; 1986;p. 566–568
  53. Silk KR, Lohr NE, Cornell DG. The dexamethasone suppression test in borderline and non-borderline affective patients. In:  McGlashan TH editors. The Borderline: Current Empirical Research. Washington, DC: American Psychiatric Press; 1985;p. 99–116
  54. Soloff PH, George A, Nathan RS. The dexamethasone suppression test in patients with borderline personality disorder. American Journal of Psychiatry. 1982;139:1621–1623
  55. Soloff PH, George A, Nathan RS, Schulz PM, Cornelius JR, Herring J, et al. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. Journal of Clinical Psychopharmacology. 1989;9:238–246
  56. Soloff PH, Cornelius J, George A. The depressed borderline: one disorder or two? Relationship between Axis I and Axis II disorders: implications for treatment. Psychopharmacology Bulletin. 1991;27:23–30
  57. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria: rationale and reliability. Archives of General Psychiatry. 1978;35:773–782
  58. Stamenkovic M, Pezawas L, De Zwaan M, Aschauer HN, Kasper S. Mirtazapine in recurrent brief depression. International Clinical Psychopharmacology. 1998;13:39–40
  59. Stamenkovic M, Blasbichier T, Riederer F, Pezawas L, Brandstatter N, Aschauer HN, et al. Fluoxetine treatment in patients with recurrent brief depression. International Clinical Psychopharmacology. 2001;16:221–226
  60. Staner L, De La Fuente JM, Kerkhofs M, Linkowski P, Mendlewicz J. Biological and clinical features in recurrent brief depression: a comparison with major depressed and healthy subjects. Journal of Affective Disorders. 1992;26:241–246
  61. Sternbach HA, Fleming J, Extein I, Pottash ALC, Gold MS. The dexamethasone suppression and thyrotopin-releasing hormone test in depressed borderline patients. Psychoneuroendocrinology. 1983;8:459–462
  62. Val E, Gaviria FM, Lahmeyer HW. Affective disorders and borderline personality. In:  Pichot P,  Berner P editor. Biological Psychiatry. Psychiatry: The State of the Art. vol. 2:New York: Plenum Press; 1985;p. 171–176
  63. Westen D, Moses J, Silk KR, Lohr NE, Cohen MA, Segal HS. Quality of depressive experience in borderline personality disorder and major depression: when depression is not just depression. Journal of Personality Disorders. 1992;6:382–393
  64. World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO; 1992;

PII: S0165-1781(04)00217-3

doi: 10.1016/j.psychres.2004.05.025

Psychiatry Research
Volume 129, Issue 1 , Pages 65-73 , 30 November 2004

Article Tools